These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6521948)

  • 1. [Resinated isoxsuprine in the therapy of cerebral ischemic vascular diseases].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1984 Nov; 75(45-46):2769-76. PubMed ID: 6521948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].
    Caneschi S; Bonaventi C; Finzi F
    Minerva Med; 1985 Oct; 76(41):1933-43. PubMed ID: 2865702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acetylsalicylic acid in the treatment of ischemic cerebrovascular disorders].
    Caneschi S; Bonaventi C; Finzi F; Tito P
    Minerva Med; 1986 Jun; 77(27):1299-308. PubMed ID: 3523307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative characteristics of the effectiveness of antiaggregant and anticoagulation therapy of ischemic stroke].
    Gorbacheva FE; Natiazhkina GM; Krutik ZI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1147-9. PubMed ID: 6624338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating platelet aggregates in cerebrovascular diseases. Preliminary data.
    Carrieri P; La Pia S; Indaco A; Pisano P; Orefice G; Iadevaia V
    Acta Neurol (Napoli); 1981 Jun; 3(3):500-4. PubMed ID: 7282470
    [No Abstract]   [Full Text] [Related]  

  • 6. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients.
    Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L
    Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
    Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-platelet aggregation therapy and ischaemic cerebral accidents due to atheroma (author's transl)].
    Autret A
    Nouv Presse Med; 1982 May; 11(20):1543-7. PubMed ID: 7099931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular risk factors in patients with ischaemic stroke. Distribution according to age, sex and stroke subtype].
    Moreno VP; García-Raso A; García-Bueno MJ; Sánchez-Sánchez C; Meseguer E; Mata R; Llamas P
    Rev Neurol; 2008 May 16-31; 46(10):593-8. PubMed ID: 18465698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute cerebral ischemia in patients under 45 years of age: a study in a series of 68 patients].
    López-Fernández JC; Aladro-Benito Y; Cubero-González A
    Rev Neurol; 1998 Oct; 27(158):640-4. PubMed ID: 9803514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study.
    Shin DH; Lee PH; Bang OY
    Arch Neurol; 2005 Aug; 62(8):1232-7. PubMed ID: 16087764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperresponsiveness of platelets in ischemic stroke.
    Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
    Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
    Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of acetylsalicylic acid and diquertin on platelet aggregation and hemorheological parameters in rats with cerebral ischemia].
    Plotnikova MB; Iamkin aV; Aliev OI; Tiukavkina NA
    Eksp Klin Farmakol; 2005; 68(2):33-5. PubMed ID: 15934364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ischemic cerebro-vascular accidents: usefulness of anticoagulant and antiaggregating agents (author's transl)].
    Cauchie C
    Rev Med Brux; 1981 Mar; 2(3):191-4. PubMed ID: 7232932
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
    Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.